COVID-19 Vaccines, Immunity & Diagnostics
As excitement soars over pending COVID-19 vaccination programmes in 2021, it is timely to know how an effective vaccine works in producing virus neutralizing antibodies in recipients that generates immunity, and how serology monitoring can measure herd immunity.
In this webinar, Prof. Wang Linfa explored the importance of serology testing in managing the next phase of COVID-19, how it may impact public health policies, and its role in enhancing our preparedness for future pandemics.
Dr. Sergio Carmona and Dr. Emma Hannay discussed the efforts of FIND in guiding and providing access to tools supporting the fight against the pandemic. This was done through the Access to COVID-19 Tools (ACT) Accelerator, an initiative led by FIND, the Global Fund, WHO and other global partners.
Speakers:
- Prof Wang Linfa, PhD, FTSE, Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore
- Dr. Sergio Carmona, Chief Medical Officer, FIND, Geneva, Switzerland
- Dr. Emma Hannay, Director Act-A Dx Secretariat, FIND, Geneva, Switzerland
- Dr. Sidney Yee, CEO, Diagnostics Development Hub, Singapore
This webinar is organised by Diagnostics Development Hub (DxD Hub) and FIND, supported by Duke-NUS, ASEAN Dx Initiative and A*StartCentral.
About ASEAN Dx Initiative
The ASEAN Diagnostics (Dx) Initiative is co-chaired by Philippine Council for Health Research and Development (PCHRD) and Singapore's Diagnostics Development Hub (DxD Hub) with the mandate to build diagnostic capacity among ASEAN member countries.
For more information – please visit https://aseandx.com/